Project
Mucociliary differentiation, bronchial epithelial cells, human (Ross 2007)
Navigation
Downloads
Results for MEIS2
Z-value: 1.18
Motif logo
Transcription factors associated with MEIS2
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
MEIS2
|
ENSG00000134138.15 | Meis homeobox 2 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| MEIS2 | hg19_v2_chr15_-_37391614_37391683 | -0.05 | 7.7e-01 | Click! |
Activity profile of MEIS2 motif
Sorted Z-values of MEIS2 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr14_-_65769392 | 6.60 |
ENST00000555736.1
|
CTD-2509G16.5
|
CTD-2509G16.5 |
| chr1_+_78956651 | 5.26 |
ENST00000370757.3
ENST00000370756.3 |
PTGFR
|
prostaglandin F receptor (FP) |
| chr19_-_9092018 | 5.07 |
ENST00000397910.4
|
MUC16
|
mucin 16, cell surface associated |
| chr6_+_32407619 | 4.85 |
ENST00000395388.2
ENST00000374982.5 |
HLA-DRA
|
major histocompatibility complex, class II, DR alpha |
| chr1_-_152131703 | 4.77 |
ENST00000316073.3
|
RPTN
|
repetin |
| chr3_+_13610216 | 4.75 |
ENST00000492059.1
|
FBLN2
|
fibulin 2 |
| chr3_+_63638339 | 4.60 |
ENST00000343837.3
ENST00000469440.1 |
SNTN
|
sentan, cilia apical structure protein |
| chr6_-_32498046 | 4.29 |
ENST00000374975.3
|
HLA-DRB5
|
major histocompatibility complex, class II, DR beta 5 |
| chr5_-_35938674 | 4.27 |
ENST00000397366.1
ENST00000513623.1 ENST00000514524.1 ENST00000397367.2 |
CAPSL
|
calcyphosine-like |
| chr4_+_69962185 | 4.10 |
ENST00000305231.7
|
UGT2B7
|
UDP glucuronosyltransferase 2 family, polypeptide B7 |
| chr4_+_69962212 | 3.82 |
ENST00000508661.1
|
UGT2B7
|
UDP glucuronosyltransferase 2 family, polypeptide B7 |
| chr6_-_33048483 | 3.69 |
ENST00000419277.1
|
HLA-DPA1
|
major histocompatibility complex, class II, DP alpha 1 |
| chr9_-_34381536 | 3.63 |
ENST00000379126.3
ENST00000379127.1 ENST00000379133.3 |
C9orf24
|
chromosome 9 open reading frame 24 |
| chr14_-_107078851 | 3.51 |
ENST00000390628.2
|
IGHV1-58
|
immunoglobulin heavy variable 1-58 |
| chr12_+_109826524 | 3.38 |
ENST00000431443.2
|
MYO1H
|
myosin IH |
| chr4_-_149365827 | 3.10 |
ENST00000344721.4
|
NR3C2
|
nuclear receptor subfamily 3, group C, member 2 |
| chr11_+_27062272 | 3.10 |
ENST00000529202.1
ENST00000533566.1 |
BBOX1
|
butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1 |
| chr19_-_9003586 | 3.02 |
ENST00000380951.5
|
MUC16
|
mucin 16, cell surface associated |
| chr12_-_25348007 | 2.89 |
ENST00000354189.5
ENST00000545133.1 ENST00000554347.1 ENST00000395987.3 ENST00000320267.9 ENST00000395990.2 ENST00000537577.1 |
CASC1
|
cancer susceptibility candidate 1 |
| chr11_+_27062860 | 2.81 |
ENST00000528583.1
|
BBOX1
|
butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1 |
| chr22_-_36013368 | 2.66 |
ENST00000442617.1
ENST00000397326.2 ENST00000397328.1 ENST00000451685.1 |
MB
|
myoglobin |
| chr1_-_146696901 | 2.64 |
ENST00000369272.3
ENST00000441068.2 |
FMO5
|
flavin containing monooxygenase 5 |
| chr20_+_31870927 | 2.61 |
ENST00000253354.1
|
BPIFB1
|
BPI fold containing family B, member 1 |
| chr9_-_34381511 | 2.59 |
ENST00000379124.1
|
C9orf24
|
chromosome 9 open reading frame 24 |
| chr11_+_27062502 | 2.48 |
ENST00000263182.3
|
BBOX1
|
butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1 |
| chr1_-_161337662 | 2.48 |
ENST00000367974.1
|
C1orf192
|
chromosome 1 open reading frame 192 |
| chr6_+_32709119 | 2.43 |
ENST00000374940.3
|
HLA-DQA2
|
major histocompatibility complex, class II, DQ alpha 2 |
| chr7_-_99573640 | 2.41 |
ENST00000411734.1
|
AZGP1
|
alpha-2-glycoprotein 1, zinc-binding |
| chr21_-_43916433 | 2.39 |
ENST00000291536.3
|
RSPH1
|
radial spoke head 1 homolog (Chlamydomonas) |
| chr7_-_99573677 | 2.39 |
ENST00000292401.4
|
AZGP1
|
alpha-2-glycoprotein 1, zinc-binding |
| chr1_+_38022572 | 2.38 |
ENST00000541606.1
|
DNALI1
|
dynein, axonemal, light intermediate chain 1 |
| chr13_-_20080080 | 2.30 |
ENST00000400103.2
|
TPTE2
|
transmembrane phosphoinositide 3-phosphatase and tensin homolog 2 |
| chr7_-_99569468 | 2.27 |
ENST00000419575.1
|
AZGP1
|
alpha-2-glycoprotein 1, zinc-binding |
| chr2_+_71162995 | 2.26 |
ENST00000234396.4
|
ATP6V1B1
|
ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1 |
| chr21_-_43916296 | 2.25 |
ENST00000398352.3
|
RSPH1
|
radial spoke head 1 homolog (Chlamydomonas) |
| chr20_+_31823792 | 2.21 |
ENST00000375413.4
ENST00000354297.4 ENST00000375422.2 |
BPIFA1
|
BPI fold containing family A, member 1 |
| chr2_+_120187465 | 2.19 |
ENST00000409826.1
ENST00000417645.1 |
TMEM37
|
transmembrane protein 37 |
| chr20_+_31749574 | 2.15 |
ENST00000253362.2
|
BPIFA2
|
BPI fold containing family A, member 2 |
| chr1_+_111888890 | 2.09 |
ENST00000369738.4
|
PIFO
|
primary cilia formation |
| chr21_+_42694732 | 2.08 |
ENST00000398646.3
|
FAM3B
|
family with sequence similarity 3, member B |
| chr7_-_16921601 | 2.03 |
ENST00000402239.3
ENST00000310398.2 ENST00000414935.1 |
AGR3
|
anterior gradient 3 |
| chr2_+_71163051 | 2.03 |
ENST00000412314.1
|
ATP6V1B1
|
ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1 |
| chr5_-_149792295 | 2.03 |
ENST00000518797.1
ENST00000524315.1 ENST00000009530.7 ENST00000377795.3 |
CD74
|
CD74 molecule, major histocompatibility complex, class II invariant chain |
| chr6_-_52668605 | 2.03 |
ENST00000334575.5
|
GSTA1
|
glutathione S-transferase alpha 1 |
| chr9_-_112970436 | 2.02 |
ENST00000400613.4
|
C9orf152
|
chromosome 9 open reading frame 152 |
| chr3_+_238273 | 2.01 |
ENST00000256509.2
|
CHL1
|
cell adhesion molecule L1-like |
| chr1_+_79115503 | 2.00 |
ENST00000370747.4
ENST00000438486.1 ENST00000545124.1 |
IFI44
|
interferon-induced protein 44 |
| chr19_+_56368803 | 1.97 |
ENST00000587891.1
|
NLRP4
|
NLR family, pyrin domain containing 4 |
| chr22_-_27620603 | 1.95 |
ENST00000418271.1
ENST00000444114.1 |
RP5-1172A22.1
|
RP5-1172A22.1 |
| chr19_-_14992264 | 1.92 |
ENST00000327462.2
|
OR7A17
|
olfactory receptor, family 7, subfamily A, member 17 |
| chr10_-_29084886 | 1.88 |
ENST00000608061.1
ENST00000443246.2 ENST00000446012.1 |
LINC00837
|
long intergenic non-protein coding RNA 837 |
| chr9_+_72435709 | 1.86 |
ENST00000377197.3
ENST00000527647.1 |
C9orf135
|
chromosome 9 open reading frame 135 |
| chr6_-_33041378 | 1.83 |
ENST00000428995.1
|
HLA-DPA1
|
major histocompatibility complex, class II, DP alpha 1 |
| chr6_+_33048222 | 1.83 |
ENST00000428835.1
|
HLA-DPB1
|
major histocompatibility complex, class II, DP beta 1 |
| chr12_+_50355647 | 1.83 |
ENST00000293599.6
|
AQP5
|
aquaporin 5 |
| chr11_+_61976137 | 1.78 |
ENST00000244930.4
|
SCGB2A1
|
secretoglobin, family 2A, member 1 |
| chr10_+_94590910 | 1.76 |
ENST00000371547.4
|
EXOC6
|
exocyst complex component 6 |
| chr14_-_54420133 | 1.74 |
ENST00000559501.1
ENST00000558984.1 |
BMP4
|
bone morphogenetic protein 4 |
| chr1_-_117753540 | 1.73 |
ENST00000328189.3
ENST00000369458.3 |
VTCN1
|
V-set domain containing T cell activation inhibitor 1 |
| chr3_-_50383096 | 1.72 |
ENST00000442887.1
ENST00000360165.3 |
ZMYND10
|
zinc finger, MYND-type containing 10 |
| chr6_+_112408768 | 1.72 |
ENST00000368656.2
ENST00000604268.1 |
FAM229B
|
family with sequence similarity 229, member B |
| chr14_-_21270995 | 1.70 |
ENST00000555698.1
ENST00000397970.4 ENST00000340900.3 |
RNASE1
|
ribonuclease, RNase A family, 1 (pancreatic) |
| chr3_-_112218378 | 1.70 |
ENST00000334529.5
|
BTLA
|
B and T lymphocyte associated |
| chr16_-_67427389 | 1.69 |
ENST00000562206.1
ENST00000290942.5 ENST00000393957.2 |
TPPP3
|
tubulin polymerization-promoting protein family member 3 |
| chr5_-_35195338 | 1.67 |
ENST00000509839.1
|
PRLR
|
prolactin receptor |
| chr10_-_123357598 | 1.65 |
ENST00000358487.5
ENST00000369058.3 ENST00000369060.4 ENST00000359354.2 |
FGFR2
|
fibroblast growth factor receptor 2 |
| chr2_+_159651821 | 1.65 |
ENST00000309950.3
ENST00000409042.1 |
DAPL1
|
death associated protein-like 1 |
| chr4_-_23891693 | 1.64 |
ENST00000264867.2
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
| chr3_+_169629354 | 1.64 |
ENST00000428432.2
ENST00000335556.3 |
SAMD7
|
sterile alpha motif domain containing 7 |
| chr20_-_35580240 | 1.62 |
ENST00000262878.4
|
SAMHD1
|
SAM domain and HD domain 1 |
| chr6_+_33043703 | 1.61 |
ENST00000418931.2
ENST00000535465.1 |
HLA-DPB1
|
major histocompatibility complex, class II, DP beta 1 |
| chr1_-_146697185 | 1.60 |
ENST00000533174.1
ENST00000254090.4 |
FMO5
|
flavin containing monooxygenase 5 |
| chr11_+_827553 | 1.60 |
ENST00000528542.2
ENST00000450448.1 |
EFCAB4A
|
EF-hand calcium binding domain 4A |
| chr11_+_101918153 | 1.58 |
ENST00000434758.2
ENST00000526781.1 ENST00000534360.1 |
C11orf70
|
chromosome 11 open reading frame 70 |
| chr4_+_75858318 | 1.57 |
ENST00000307428.7
|
PARM1
|
prostate androgen-regulated mucin-like protein 1 |
| chr1_+_47533160 | 1.57 |
ENST00000334194.3
|
CYP4Z1
|
cytochrome P450, family 4, subfamily Z, polypeptide 1 |
| chr4_-_149363662 | 1.56 |
ENST00000355292.3
ENST00000358102.3 |
NR3C2
|
nuclear receptor subfamily 3, group C, member 2 |
| chr7_+_101917407 | 1.56 |
ENST00000487284.1
|
CUX1
|
cut-like homeobox 1 |
| chr5_+_140220769 | 1.55 |
ENST00000531613.1
ENST00000378123.3 |
PCDHA8
|
protocadherin alpha 8 |
| chr6_-_52774464 | 1.53 |
ENST00000370968.1
ENST00000211122.3 |
GSTA3
|
glutathione S-transferase alpha 3 |
| chr1_+_104293028 | 1.52 |
ENST00000370079.3
|
AMY1C
|
amylase, alpha 1C (salivary) |
| chr20_-_35580104 | 1.51 |
ENST00000373694.5
|
SAMHD1
|
SAM domain and HD domain 1 |
| chr6_-_32557610 | 1.50 |
ENST00000360004.5
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1 |
| chr6_+_131958436 | 1.50 |
ENST00000357639.3
ENST00000543135.1 ENST00000427148.2 ENST00000358229.5 |
ENPP3
|
ectonucleotide pyrophosphatase/phosphodiesterase 3 |
| chr9_-_130635741 | 1.50 |
ENST00000223836.10
|
AK1
|
adenylate kinase 1 |
| chr8_-_110620284 | 1.49 |
ENST00000529690.1
|
SYBU
|
syntabulin (syntaxin-interacting) |
| chr6_+_43612750 | 1.49 |
ENST00000372165.4
ENST00000372163.4 |
RSPH9
|
radial spoke head 9 homolog (Chlamydomonas) |
| chr12_-_71533055 | 1.47 |
ENST00000552128.1
|
TSPAN8
|
tetraspanin 8 |
| chr14_+_105952648 | 1.47 |
ENST00000330233.7
|
CRIP1
|
cysteine-rich protein 1 (intestinal) |
| chr4_-_70518941 | 1.47 |
ENST00000286604.4
ENST00000505512.1 ENST00000514019.1 |
UGT2A1
UGT2A1
|
UDP glucuronosyltransferase 2 family, polypeptide A1, complex locus UDP glucuronosyltransferase 2 family, polypeptide A1, complex locus |
| chr16_-_55866997 | 1.47 |
ENST00000360526.3
ENST00000361503.4 |
CES1
|
carboxylesterase 1 |
| chr17_+_53343577 | 1.47 |
ENST00000573945.1
|
HLF
|
hepatic leukemia factor |
| chr17_+_26800296 | 1.46 |
ENST00000444914.3
ENST00000314669.5 |
SLC13A2
|
solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2 |
| chr12_+_111051902 | 1.45 |
ENST00000397655.3
ENST00000471804.2 ENST00000377654.3 ENST00000397659.4 |
TCTN1
|
tectonic family member 1 |
| chr5_+_156693159 | 1.43 |
ENST00000347377.6
|
CYFIP2
|
cytoplasmic FMR1 interacting protein 2 |
| chr1_+_104159999 | 1.42 |
ENST00000414303.2
ENST00000423678.1 |
AMY2A
|
amylase, alpha 2A (pancreatic) |
| chr6_-_32920794 | 1.42 |
ENST00000395305.3
ENST00000395303.3 ENST00000374843.4 ENST00000429234.1 |
HLA-DMA
XXbac-BPG181M17.5
|
major histocompatibility complex, class II, DM alpha Uncharacterized protein |
| chr11_+_73661364 | 1.40 |
ENST00000339764.1
|
DNAJB13
|
DnaJ (Hsp40) homolog, subfamily B, member 13 |
| chr3_-_120365866 | 1.39 |
ENST00000475447.2
|
HGD
|
homogentisate 1,2-dioxygenase |
| chr5_+_156693091 | 1.38 |
ENST00000318218.6
ENST00000442283.2 ENST00000522463.1 ENST00000521420.1 |
CYFIP2
|
cytoplasmic FMR1 interacting protein 2 |
| chr9_+_127615733 | 1.38 |
ENST00000373574.1
|
WDR38
|
WD repeat domain 38 |
| chr7_-_137028534 | 1.38 |
ENST00000348225.2
|
PTN
|
pleiotrophin |
| chr1_-_46598371 | 1.35 |
ENST00000372006.1
ENST00000425892.1 ENST00000420542.1 ENST00000354242.4 ENST00000340332.6 |
PIK3R3
|
phosphoinositide-3-kinase, regulatory subunit 3 (gamma) |
| chr11_+_111385497 | 1.35 |
ENST00000375618.4
ENST00000529167.1 ENST00000332814.6 |
C11orf88
|
chromosome 11 open reading frame 88 |
| chr18_-_45935663 | 1.35 |
ENST00000589194.1
ENST00000591279.1 ENST00000590855.1 ENST00000587107.1 ENST00000588970.1 ENST00000586525.1 ENST00000592387.1 ENST00000590800.1 |
ZBTB7C
|
zinc finger and BTB domain containing 7C |
| chr2_+_132286754 | 1.34 |
ENST00000434330.1
|
CCDC74A
|
coiled-coil domain containing 74A |
| chr16_+_19467772 | 1.34 |
ENST00000219821.5
ENST00000561503.1 ENST00000564959.1 |
TMC5
|
transmembrane channel-like 5 |
| chr11_-_26593779 | 1.34 |
ENST00000529533.1
|
MUC15
|
mucin 15, cell surface associated |
| chr10_+_51549498 | 1.33 |
ENST00000358559.2
ENST00000298239.6 |
MSMB
|
microseminoprotein, beta- |
| chr3_-_45957534 | 1.33 |
ENST00000536047.1
|
LZTFL1
|
leucine zipper transcription factor-like 1 |
| chr5_+_140602904 | 1.32 |
ENST00000515856.2
ENST00000239449.4 |
PCDHB14
|
protocadherin beta 14 |
| chr11_-_111781554 | 1.29 |
ENST00000526167.1
ENST00000528961.1 |
CRYAB
|
crystallin, alpha B |
| chr11_-_26593677 | 1.29 |
ENST00000527569.1
|
MUC15
|
mucin 15, cell surface associated |
| chr7_+_149571045 | 1.28 |
ENST00000479613.1
ENST00000606024.1 ENST00000464662.1 ENST00000425642.2 |
ATP6V0E2
|
ATPase, H+ transporting V0 subunit e2 |
| chr1_+_61330931 | 1.28 |
ENST00000371191.1
|
NFIA
|
nuclear factor I/A |
| chr5_-_137475071 | 1.27 |
ENST00000265191.2
|
NME5
|
NME/NM23 family member 5 |
| chr17_+_41158742 | 1.26 |
ENST00000415816.2
ENST00000438323.2 |
IFI35
|
interferon-induced protein 35 |
| chr1_-_109655355 | 1.26 |
ENST00000369945.3
|
C1orf194
|
chromosome 1 open reading frame 194 |
| chr19_-_9006766 | 1.26 |
ENST00000599436.1
|
MUC16
|
mucin 16, cell surface associated |
| chr12_+_101188547 | 1.26 |
ENST00000546991.1
ENST00000392979.3 |
ANO4
|
anoctamin 4 |
| chr22_+_31518938 | 1.25 |
ENST00000412985.1
ENST00000331075.5 ENST00000412277.2 ENST00000420017.1 ENST00000400294.2 ENST00000405300.1 ENST00000404390.3 |
INPP5J
|
inositol polyphosphate-5-phosphatase J |
| chr1_-_27998689 | 1.25 |
ENST00000339145.4
ENST00000362020.4 ENST00000361157.6 |
IFI6
|
interferon, alpha-inducible protein 6 |
| chr3_+_158288942 | 1.25 |
ENST00000491767.1
ENST00000355893.5 |
MLF1
|
myeloid leukemia factor 1 |
| chr1_-_109655377 | 1.25 |
ENST00000369948.3
|
C1orf194
|
chromosome 1 open reading frame 194 |
| chr1_+_85527987 | 1.23 |
ENST00000326813.8
ENST00000294664.6 ENST00000528899.1 |
WDR63
|
WD repeat domain 63 |
| chr9_-_130637244 | 1.22 |
ENST00000373156.1
|
AK1
|
adenylate kinase 1 |
| chr2_+_132287237 | 1.22 |
ENST00000467992.2
|
CCDC74A
|
coiled-coil domain containing 74A |
| chr5_-_160279207 | 1.21 |
ENST00000327245.5
|
ATP10B
|
ATPase, class V, type 10B |
| chr19_-_12662314 | 1.21 |
ENST00000339282.7
ENST00000596193.1 |
ZNF564
|
zinc finger protein 564 |
| chr6_+_30951487 | 1.20 |
ENST00000486149.2
ENST00000376296.3 |
MUC21
|
mucin 21, cell surface associated |
| chr17_+_26800648 | 1.20 |
ENST00000545060.1
|
SLC13A2
|
solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2 |
| chr12_+_49297899 | 1.17 |
ENST00000552942.1
ENST00000320516.4 |
CCDC65
|
coiled-coil domain containing 65 |
| chr3_+_158288960 | 1.17 |
ENST00000484955.1
ENST00000359117.5 ENST00000498592.1 ENST00000477042.1 ENST00000471745.1 ENST00000469452.1 |
MLF1
|
myeloid leukemia factor 1 |
| chr12_+_101188718 | 1.16 |
ENST00000299222.9
ENST00000392977.3 |
ANO4
|
anoctamin 4 |
| chr2_+_24714729 | 1.16 |
ENST00000406961.1
ENST00000405141.1 |
NCOA1
|
nuclear receptor coactivator 1 |
| chr5_-_41261540 | 1.16 |
ENST00000263413.3
|
C6
|
complement component 6 |
| chr14_-_94854926 | 1.16 |
ENST00000402629.1
ENST00000556091.1 ENST00000554720.1 |
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 |
| chr6_-_46922659 | 1.16 |
ENST00000265417.7
|
GPR116
|
G protein-coupled receptor 116 |
| chr5_+_140165876 | 1.14 |
ENST00000504120.2
ENST00000394633.3 ENST00000378133.3 |
PCDHA1
|
protocadherin alpha 1 |
| chr15_+_71228826 | 1.14 |
ENST00000558456.1
ENST00000560158.2 ENST00000558808.1 ENST00000559806.1 ENST00000559069.1 |
LRRC49
|
leucine rich repeat containing 49 |
| chr8_+_72587535 | 1.12 |
ENST00000519840.1
ENST00000521131.1 |
RP11-1144P22.1
|
RP11-1144P22.1 |
| chr22_+_31003190 | 1.12 |
ENST00000407817.3
|
TCN2
|
transcobalamin II |
| chr11_-_26593649 | 1.12 |
ENST00000455601.2
|
MUC15
|
mucin 15, cell surface associated |
| chr8_+_99076750 | 1.11 |
ENST00000545282.1
|
C8orf47
|
chromosome 8 open reading frame 47 |
| chr6_+_32605195 | 1.11 |
ENST00000374949.2
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1 |
| chr5_-_16509101 | 1.11 |
ENST00000399793.2
|
FAM134B
|
family with sequence similarity 134, member B |
| chr19_+_17982747 | 1.11 |
ENST00000222248.3
|
SLC5A5
|
solute carrier family 5 (sodium/iodide cotransporter), member 5 |
| chr5_+_156696362 | 1.10 |
ENST00000377576.3
|
CYFIP2
|
cytoplasmic FMR1 interacting protein 2 |
| chr4_+_165675269 | 1.10 |
ENST00000507311.1
|
RP11-294O2.2
|
RP11-294O2.2 |
| chr15_-_43559055 | 1.09 |
ENST00000220420.5
ENST00000349114.4 |
TGM5
|
transglutaminase 5 |
| chr14_-_106330458 | 1.09 |
ENST00000461719.1
|
IGHJ4
|
immunoglobulin heavy joining 4 |
| chr11_-_108464465 | 1.09 |
ENST00000525344.1
|
EXPH5
|
exophilin 5 |
| chr13_+_43355683 | 1.08 |
ENST00000537894.1
|
FAM216B
|
family with sequence similarity 216, member B |
| chr5_-_101632153 | 1.07 |
ENST00000310954.6
|
SLCO4C1
|
solute carrier organic anion transporter family, member 4C1 |
| chr10_+_114135004 | 1.07 |
ENST00000393081.1
|
ACSL5
|
acyl-CoA synthetase long-chain family member 5 |
| chr1_+_162351503 | 1.07 |
ENST00000458626.2
|
C1orf226
|
chromosome 1 open reading frame 226 |
| chr12_+_8234807 | 1.06 |
ENST00000339754.5
|
NECAP1
|
NECAP endocytosis associated 1 |
| chr14_-_94856987 | 1.06 |
ENST00000449399.3
ENST00000404814.4 |
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 |
| chr11_-_111781610 | 1.06 |
ENST00000525823.1
|
CRYAB
|
crystallin, alpha B |
| chr21_-_43735628 | 1.06 |
ENST00000291525.10
ENST00000518498.1 |
TFF3
|
trefoil factor 3 (intestinal) |
| chr11_+_73358594 | 1.06 |
ENST00000227214.6
ENST00000398494.4 ENST00000543085.1 |
PLEKHB1
|
pleckstrin homology domain containing, family B (evectins) member 1 |
| chr9_+_124922171 | 1.05 |
ENST00000373764.3
ENST00000536616.1 |
MORN5
|
MORN repeat containing 5 |
| chr16_+_84209539 | 1.03 |
ENST00000569735.1
|
DNAAF1
|
dynein, axonemal, assembly factor 1 |
| chr15_+_78558523 | 1.02 |
ENST00000446172.2
|
DNAJA4
|
DnaJ (Hsp40) homolog, subfamily A, member 4 |
| chr12_+_111051832 | 1.02 |
ENST00000550703.2
ENST00000551590.1 |
TCTN1
|
tectonic family member 1 |
| chr7_-_137028498 | 1.02 |
ENST00000393083.2
|
PTN
|
pleiotrophin |
| chr3_-_52486841 | 1.01 |
ENST00000496590.1
|
TNNC1
|
troponin C type 1 (slow) |
| chr12_+_6561190 | 1.00 |
ENST00000544021.1
ENST00000266556.7 |
TAPBPL
|
TAP binding protein-like |
| chr4_+_165675197 | 1.00 |
ENST00000515485.1
|
RP11-294O2.2
|
RP11-294O2.2 |
| chr7_+_105603683 | 0.99 |
ENST00000317716.9
|
CDHR3
|
cadherin-related family member 3 |
| chr14_-_21492113 | 0.99 |
ENST00000554094.1
|
NDRG2
|
NDRG family member 2 |
| chr21_-_43735446 | 0.99 |
ENST00000398431.2
|
TFF3
|
trefoil factor 3 (intestinal) |
| chr5_+_36608422 | 0.98 |
ENST00000381918.3
|
SLC1A3
|
solute carrier family 1 (glial high affinity glutamate transporter), member 3 |
| chr11_+_66742742 | 0.98 |
ENST00000308963.4
|
C11orf86
|
chromosome 11 open reading frame 86 |
| chr10_+_114135952 | 0.97 |
ENST00000356116.1
ENST00000433418.1 ENST00000354273.4 |
ACSL5
|
acyl-CoA synthetase long-chain family member 5 |
| chr16_-_55867146 | 0.97 |
ENST00000422046.2
|
CES1
|
carboxylesterase 1 |
| chr3_-_100712352 | 0.96 |
ENST00000471714.1
ENST00000284322.5 |
ABI3BP
|
ABI family, member 3 (NESH) binding protein |
| chr8_+_76452097 | 0.96 |
ENST00000396423.2
|
HNF4G
|
hepatocyte nuclear factor 4, gamma |
| chr22_+_31003133 | 0.96 |
ENST00000405742.3
|
TCN2
|
transcobalamin II |
| chr1_-_159880159 | 0.94 |
ENST00000599780.1
|
AL590560.1
|
HCG1995379; Uncharacterized protein |
| chr3_+_113616317 | 0.94 |
ENST00000440446.2
ENST00000488680.1 |
GRAMD1C
|
GRAM domain containing 1C |
| chr11_-_5248294 | 0.94 |
ENST00000335295.4
|
HBB
|
hemoglobin, beta |
| chr14_+_75988768 | 0.94 |
ENST00000286639.6
|
BATF
|
basic leucine zipper transcription factor, ATF-like |
| chr16_+_2880157 | 0.94 |
ENST00000382280.3
|
ZG16B
|
zymogen granule protein 16B |
| chr9_-_3469181 | 0.94 |
ENST00000366116.2
|
AL365202.1
|
Uncharacterized protein |
| chr16_+_82068830 | 0.94 |
ENST00000199936.4
|
HSD17B2
|
hydroxysteroid (17-beta) dehydrogenase 2 |
| chr16_+_2588012 | 0.94 |
ENST00000354836.5
ENST00000389224.3 |
PDPK1
|
3-phosphoinositide dependent protein kinase-1 |
| chr7_-_73184588 | 0.93 |
ENST00000395145.2
|
CLDN3
|
claudin 3 |
| chr1_-_46089718 | 0.92 |
ENST00000421127.2
ENST00000343901.2 ENST00000528266.1 |
CCDC17
|
coiled-coil domain containing 17 |
| chr16_-_12897642 | 0.92 |
ENST00000433677.2
ENST00000261660.4 ENST00000381774.4 |
CPPED1
|
calcineurin-like phosphoesterase domain containing 1 |
| chr7_+_147830776 | 0.92 |
ENST00000538075.1
|
CNTNAP2
|
contactin associated protein-like 2 |
| chr15_-_82338460 | 0.92 |
ENST00000558133.1
ENST00000329713.4 |
MEX3B
|
mex-3 RNA binding family member B |
| chr6_-_24911195 | 0.92 |
ENST00000259698.4
|
FAM65B
|
family with sequence similarity 65, member B |
| chr15_+_43809797 | 0.92 |
ENST00000399453.1
ENST00000300231.5 |
MAP1A
|
microtubule-associated protein 1A |
| chr19_+_56717283 | 0.91 |
ENST00000376267.1
|
ZSCAN5C
|
zinc finger and SCAN domain containing 5C |
| chr17_+_68165657 | 0.91 |
ENST00000243457.3
|
KCNJ2
|
potassium inwardly-rectifying channel, subfamily J, member 2 |
| chr7_-_112430427 | 0.91 |
ENST00000449743.1
ENST00000441474.1 ENST00000454074.1 ENST00000447395.1 |
TMEM168
|
transmembrane protein 168 |
| chr14_+_75988851 | 0.91 |
ENST00000555504.1
|
BATF
|
basic leucine zipper transcription factor, ATF-like |
| chr1_+_38022513 | 0.90 |
ENST00000296218.7
|
DNALI1
|
dynein, axonemal, light intermediate chain 1 |
| chr6_-_134639180 | 0.90 |
ENST00000367858.5
|
SGK1
|
serum/glucocorticoid regulated kinase 1 |
Network of associatons between targets according to the STRING database.
First level regulatory network of MEIS2
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.6 | 6.3 | GO:0002503 | peptide antigen assembly with MHC class II protein complex(GO:0002503) |
| 1.5 | 1.5 | GO:0002399 | MHC class II protein complex assembly(GO:0002399) |
| 1.1 | 3.4 | GO:0035604 | fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow(GO:0035602) fibroblast growth factor receptor signaling pathway involved in hemopoiesis(GO:0035603) fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow(GO:0035604) |
| 0.8 | 9.2 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
| 0.8 | 2.4 | GO:1904397 | negative regulation of neuromuscular junction development(GO:1904397) |
| 0.7 | 0.7 | GO:0061097 | regulation of protein tyrosine kinase activity(GO:0061097) positive regulation of protein tyrosine kinase activity(GO:0061098) |
| 0.7 | 2.2 | GO:0010430 | fatty acid omega-oxidation(GO:0010430) |
| 0.7 | 2.0 | GO:1903567 | negative regulation of protein localization to cilium(GO:1903565) regulation of protein localization to ciliary membrane(GO:1903567) negative regulation of protein localization to ciliary membrane(GO:1903568) |
| 0.6 | 1.9 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
| 0.6 | 3.1 | GO:0006203 | dGTP catabolic process(GO:0006203) |
| 0.6 | 0.6 | GO:0060667 | fibroblast growth factor receptor signaling pathway involved in mammary gland specification(GO:0060595) mammary gland bud formation(GO:0060615) branch elongation involved in salivary gland morphogenesis(GO:0060667) mesenchymal cell differentiation involved in lung development(GO:0060915) |
| 0.6 | 2.4 | GO:0090119 | vesicle-mediated cholesterol transport(GO:0090119) |
| 0.6 | 2.4 | GO:1900190 | biofilm formation(GO:0042710) single-species biofilm formation(GO:0044010) single-species biofilm formation in or on host organism(GO:0044407) regulation of single-species biofilm formation(GO:1900190) negative regulation of single-species biofilm formation(GO:1900191) regulation of single-species biofilm formation in or on host organism(GO:1900228) negative regulation of single-species biofilm formation in or on host organism(GO:1900229) |
| 0.6 | 1.7 | GO:0061216 | apoptotic process involved in endocardial cushion morphogenesis(GO:0003277) intermediate mesoderm morphogenesis(GO:0048390) intermediate mesoderm formation(GO:0048391) intermediate mesodermal cell differentiation(GO:0048392) regulation of cardiac muscle fiber development(GO:0055018) positive regulation of cardiac muscle fiber development(GO:0055020) bud dilation involved in lung branching(GO:0060503) BMP signaling pathway involved in ureter morphogenesis(GO:0061149) renal system segmentation(GO:0061150) BMP signaling pathway involved in renal system segmentation(GO:0061151) pulmonary artery endothelial tube morphogenesis(GO:0061155) regulation of transcription from RNA polymerase II promoter involved in mesonephros development(GO:0061216) BMP signaling pathway involved in nephric duct formation(GO:0071893) negative regulation of branch elongation involved in ureteric bud branching(GO:0072096) negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway(GO:0072097) anterior/posterior pattern specification involved in ureteric bud development(GO:0072099) specification of ureteric bud anterior/posterior symmetry(GO:0072100) specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway(GO:0072101) ureter epithelial cell differentiation(GO:0072192) negative regulation of mesenchymal cell proliferation involved in ureter development(GO:0072200) positive regulation of cell proliferation involved in outflow tract morphogenesis(GO:1901964) cardiac jelly development(GO:1905072) regulation of metanephric S-shaped body morphogenesis(GO:2000004) negative regulation of metanephric S-shaped body morphogenesis(GO:2000005) regulation of metanephric comma-shaped body morphogenesis(GO:2000006) negative regulation of metanephric comma-shaped body morphogenesis(GO:2000007) |
| 0.5 | 3.6 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
| 0.5 | 0.5 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
| 0.5 | 4.6 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
| 0.5 | 1.5 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
| 0.5 | 1.4 | GO:1901860 | positive regulation of mitochondrial DNA metabolic process(GO:1901860) |
| 0.5 | 1.4 | GO:0071109 | superior temporal gyrus development(GO:0071109) |
| 0.5 | 0.9 | GO:0030185 | nitric oxide transport(GO:0030185) |
| 0.5 | 1.4 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
| 0.5 | 1.8 | GO:0001970 | positive regulation of activation of membrane attack complex(GO:0001970) |
| 0.4 | 1.7 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.4 | 0.4 | GO:2000359 | acrosomal vesicle exocytosis(GO:0060478) regulation of binding of sperm to zona pellucida(GO:2000359) negative regulation of binding of sperm to zona pellucida(GO:2000360) |
| 0.4 | 4.6 | GO:0006824 | cobalt ion transport(GO:0006824) |
| 0.4 | 1.7 | GO:0005986 | sucrose biosynthetic process(GO:0005986) |
| 0.4 | 1.2 | GO:1904897 | regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
| 0.4 | 8.7 | GO:0052695 | cellular glucuronidation(GO:0052695) |
| 0.4 | 3.7 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 0.4 | 3.2 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
| 0.4 | 2.1 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
| 0.3 | 1.0 | GO:0002590 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) |
| 0.3 | 2.7 | GO:0002606 | positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
| 0.3 | 0.3 | GO:0048389 | intermediate mesoderm development(GO:0048389) pattern specification involved in mesonephros development(GO:0061227) anterior/posterior pattern specification involved in kidney development(GO:0072098) |
| 0.3 | 0.3 | GO:1902175 | regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902175) negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902176) |
| 0.3 | 1.6 | GO:0015670 | carbon dioxide transport(GO:0015670) |
| 0.3 | 1.9 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
| 0.3 | 2.6 | GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
| 0.3 | 2.2 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
| 0.3 | 1.0 | GO:0071418 | cellular response to amine stimulus(GO:0071418) |
| 0.3 | 0.3 | GO:0006097 | glyoxylate cycle(GO:0006097) |
| 0.3 | 0.6 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
| 0.3 | 1.5 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
| 0.3 | 1.2 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
| 0.3 | 2.3 | GO:0061589 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylserine scrambling(GO:0061589) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
| 0.3 | 1.2 | GO:1990502 | dense core granule maturation(GO:1990502) |
| 0.3 | 0.9 | GO:0042351 | 'de novo' GDP-L-fucose biosynthetic process(GO:0042351) |
| 0.3 | 1.1 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
| 0.3 | 0.9 | GO:1904868 | telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
| 0.3 | 1.4 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
| 0.3 | 1.6 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
| 0.3 | 1.9 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.3 | 4.7 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 0.3 | 2.0 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
| 0.2 | 1.0 | GO:0071231 | cellular response to folic acid(GO:0071231) |
| 0.2 | 0.2 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
| 0.2 | 1.2 | GO:0072233 | thick ascending limb development(GO:0072023) metanephric thick ascending limb development(GO:0072233) |
| 0.2 | 0.2 | GO:0042713 | sperm ejaculation(GO:0042713) |
| 0.2 | 1.7 | GO:0023021 | termination of signal transduction(GO:0023021) |
| 0.2 | 0.7 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
| 0.2 | 0.7 | GO:0097018 | renal albumin absorption(GO:0097018) regulation of renal albumin absorption(GO:2000532) regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000583) negative regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000584) |
| 0.2 | 1.2 | GO:0006740 | NADPH regeneration(GO:0006740) |
| 0.2 | 0.9 | GO:2001153 | regulation of renal water transport(GO:2001151) positive regulation of renal water transport(GO:2001153) |
| 0.2 | 0.9 | GO:2000563 | positive regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000563) |
| 0.2 | 1.1 | GO:0002415 | immune response in mucosal-associated lymphoid tissue(GO:0002386) immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
| 0.2 | 2.9 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
| 0.2 | 0.7 | GO:0090076 | relaxation of skeletal muscle(GO:0090076) |
| 0.2 | 1.5 | GO:0044245 | polysaccharide digestion(GO:0044245) |
| 0.2 | 0.4 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
| 0.2 | 1.5 | GO:0071461 | cellular response to redox state(GO:0071461) |
| 0.2 | 0.9 | GO:1902361 | mitochondrial pyruvate transport(GO:0006850) mitochondrial pyruvate transmembrane transport(GO:1902361) |
| 0.2 | 0.2 | GO:2000617 | positive regulation of histone H3-K9 acetylation(GO:2000617) |
| 0.2 | 0.6 | GO:0042495 | detection of triacyl bacterial lipopeptide(GO:0042495) detection of bacterial lipopeptide(GO:0070340) |
| 0.2 | 0.6 | GO:0032203 | telomere formation via telomerase(GO:0032203) |
| 0.2 | 0.8 | GO:1900827 | maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 0.2 | 0.6 | GO:2000661 | positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
| 0.2 | 1.2 | GO:1902731 | negative regulation of chondrocyte proliferation(GO:1902731) |
| 0.2 | 0.6 | GO:2000566 | positive regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000566) |
| 0.2 | 1.6 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 0.2 | 0.6 | GO:0061181 | regulation of chondrocyte development(GO:0061181) |
| 0.2 | 0.6 | GO:0032764 | negative regulation of mast cell cytokine production(GO:0032764) |
| 0.2 | 1.2 | GO:0006540 | glutamate decarboxylation to succinate(GO:0006540) |
| 0.2 | 1.9 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
| 0.2 | 0.2 | GO:0070668 | mast cell proliferation(GO:0070662) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
| 0.2 | 0.6 | GO:0035698 | CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:0035698) positive regulation of necroptotic process(GO:0060545) regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:2000452) |
| 0.2 | 0.4 | GO:0002125 | maternal aggressive behavior(GO:0002125) |
| 0.2 | 2.6 | GO:0006108 | malate metabolic process(GO:0006108) |
| 0.2 | 1.5 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
| 0.2 | 0.9 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
| 0.2 | 0.7 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
| 0.2 | 2.9 | GO:0015866 | ADP transport(GO:0015866) |
| 0.2 | 1.1 | GO:0072675 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
| 0.2 | 1.6 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
| 0.2 | 0.7 | GO:0009236 | cobalamin biosynthetic process(GO:0009236) |
| 0.2 | 0.7 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.2 | 1.6 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
| 0.2 | 0.5 | GO:1902997 | regulation of choline O-acetyltransferase activity(GO:1902769) positive regulation of choline O-acetyltransferase activity(GO:1902771) negative regulation of tau-protein kinase activity(GO:1902948) positive regulation of early endosome to recycling endosome transport(GO:1902955) negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902960) negative regulation of neurofibrillary tangle assembly(GO:1902997) negative regulation of aspartic-type peptidase activity(GO:1905246) |
| 0.2 | 6.6 | GO:0090383 | phagosome acidification(GO:0090383) |
| 0.2 | 0.7 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
| 0.2 | 0.7 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
| 0.2 | 0.5 | GO:0018874 | benzoate metabolic process(GO:0018874) |
| 0.2 | 0.2 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
| 0.2 | 0.2 | GO:0033092 | positive regulation of immature T cell proliferation in thymus(GO:0033092) |
| 0.2 | 1.1 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
| 0.2 | 0.2 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
| 0.2 | 0.5 | GO:2001160 | regulation of histone H3-K79 methylation(GO:2001160) positive regulation of histone H3-K79 methylation(GO:2001162) |
| 0.2 | 0.5 | GO:1903697 | negative regulation of microvillus assembly(GO:1903697) |
| 0.2 | 0.3 | GO:0072204 | cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
| 0.2 | 0.8 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 0.2 | 0.5 | GO:0050757 | thymidylate synthase biosynthetic process(GO:0050757) regulation of thymidylate synthase biosynthetic process(GO:0050758) negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
| 0.1 | 0.1 | GO:2000822 | regulation of fear response(GO:1903365) regulation of behavioral fear response(GO:2000822) |
| 0.1 | 0.3 | GO:0090291 | negative regulation of osteoclast proliferation(GO:0090291) |
| 0.1 | 0.3 | GO:0009644 | response to high light intensity(GO:0009644) |
| 0.1 | 0.1 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) establishment of macromolecular complex localization to telomere(GO:0097695) |
| 0.1 | 0.3 | GO:0035904 | aorta development(GO:0035904) |
| 0.1 | 0.7 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
| 0.1 | 6.1 | GO:0035082 | axoneme assembly(GO:0035082) |
| 0.1 | 0.3 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
| 0.1 | 0.7 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
| 0.1 | 0.9 | GO:0006196 | AMP catabolic process(GO:0006196) |
| 0.1 | 1.9 | GO:0003351 | epithelial cilium movement(GO:0003351) |
| 0.1 | 1.0 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
| 0.1 | 2.0 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
| 0.1 | 2.4 | GO:0015671 | gas transport(GO:0015669) oxygen transport(GO:0015671) |
| 0.1 | 0.6 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
| 0.1 | 1.0 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
| 0.1 | 0.7 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
| 0.1 | 1.0 | GO:0032479 | regulation of type I interferon production(GO:0032479) |
| 0.1 | 0.3 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
| 0.1 | 0.4 | GO:0007412 | axon target recognition(GO:0007412) |
| 0.1 | 0.3 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
| 0.1 | 0.1 | GO:2000468 | regulation of peroxidase activity(GO:2000468) |
| 0.1 | 0.4 | GO:0045897 | positive regulation of transcription during mitosis(GO:0045897) |
| 0.1 | 0.4 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
| 0.1 | 0.1 | GO:0033006 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
| 0.1 | 0.5 | GO:0042357 | thiamine diphosphate metabolic process(GO:0042357) |
| 0.1 | 0.5 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
| 0.1 | 0.3 | GO:1901143 | insulin catabolic process(GO:1901143) |
| 0.1 | 0.8 | GO:0001575 | globoside metabolic process(GO:0001575) |
| 0.1 | 0.4 | GO:0035470 | positive regulation of vascular wound healing(GO:0035470) regulation of lactation(GO:1903487) |
| 0.1 | 0.7 | GO:0003051 | angiotensin-mediated drinking behavior(GO:0003051) |
| 0.1 | 0.5 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
| 0.1 | 0.7 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
| 0.1 | 0.5 | GO:2000691 | negative regulation of cardioblast differentiation(GO:0051892) regulation of cardiac muscle cell myoblast differentiation(GO:2000690) negative regulation of cardiac muscle cell myoblast differentiation(GO:2000691) |
| 0.1 | 5.5 | GO:0050912 | detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
| 0.1 | 0.7 | GO:0034227 | tRNA thio-modification(GO:0034227) |
| 0.1 | 0.1 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
| 0.1 | 0.8 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
| 0.1 | 0.3 | GO:0002879 | positive regulation of acute inflammatory response to non-antigenic stimulus(GO:0002879) |
| 0.1 | 0.4 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
| 0.1 | 0.4 | GO:0071284 | cellular response to lead ion(GO:0071284) |
| 0.1 | 0.5 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
| 0.1 | 0.1 | GO:2001279 | regulation of prostaglandin biosynthetic process(GO:0031392) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) |
| 0.1 | 10.1 | GO:0016266 | O-glycan processing(GO:0016266) |
| 0.1 | 0.1 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
| 0.1 | 1.2 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
| 0.1 | 0.2 | GO:0016094 | polyprenol biosynthetic process(GO:0016094) |
| 0.1 | 0.4 | GO:1904924 | negative regulation of mitophagy in response to mitochondrial depolarization(GO:1904924) |
| 0.1 | 0.7 | GO:0061055 | myotome development(GO:0061055) |
| 0.1 | 0.7 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) |
| 0.1 | 0.6 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 0.1 | 0.4 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
| 0.1 | 0.6 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
| 0.1 | 0.3 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
| 0.1 | 0.5 | GO:0036269 | swimming behavior(GO:0036269) |
| 0.1 | 0.3 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
| 0.1 | 0.1 | GO:0042350 | GDP-L-fucose biosynthetic process(GO:0042350) |
| 0.1 | 0.6 | GO:0072719 | cellular response to cisplatin(GO:0072719) |
| 0.1 | 0.2 | GO:1904020 | regulation of G-protein coupled receptor internalization(GO:1904020) |
| 0.1 | 0.3 | GO:1901189 | positive regulation of ephrin receptor signaling pathway(GO:1901189) positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901297) positive regulation of canonical Wnt signaling pathway involved in heart development(GO:1905068) |
| 0.1 | 0.7 | GO:0036111 | very long-chain fatty-acyl-CoA metabolic process(GO:0036111) |
| 0.1 | 0.4 | GO:0018094 | protein polyglycylation(GO:0018094) |
| 0.1 | 2.2 | GO:0002320 | lymphoid progenitor cell differentiation(GO:0002320) |
| 0.1 | 0.3 | GO:0021919 | BMP signaling pathway involved in spinal cord dorsal/ventral patterning(GO:0021919) |
| 0.1 | 0.1 | GO:0002625 | regulation of T cell antigen processing and presentation(GO:0002625) |
| 0.1 | 2.3 | GO:0072189 | ureter development(GO:0072189) |
| 0.1 | 1.1 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
| 0.1 | 0.4 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
| 0.1 | 1.1 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
| 0.1 | 0.7 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
| 0.1 | 3.9 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
| 0.1 | 0.2 | GO:1901536 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
| 0.1 | 3.2 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
| 0.1 | 0.4 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
| 0.1 | 0.6 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
| 0.1 | 0.1 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
| 0.1 | 1.3 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
| 0.1 | 0.6 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
| 0.1 | 1.0 | GO:0007035 | vacuolar acidification(GO:0007035) |
| 0.1 | 0.3 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
| 0.1 | 0.5 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
| 0.1 | 0.9 | GO:0006552 | leucine catabolic process(GO:0006552) |
| 0.1 | 0.2 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
| 0.1 | 0.3 | GO:0061056 | sclerotome development(GO:0061056) |
| 0.1 | 0.7 | GO:1900004 | negative regulation of serine-type endopeptidase activity(GO:1900004) negative regulation of serine-type peptidase activity(GO:1902572) |
| 0.1 | 0.4 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
| 0.1 | 0.2 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
| 0.1 | 0.4 | GO:1905069 | allantois development(GO:1905069) |
| 0.1 | 0.3 | GO:0042489 | negative regulation of odontogenesis of dentin-containing tooth(GO:0042489) |
| 0.1 | 0.5 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
| 0.1 | 0.3 | GO:0021986 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
| 0.1 | 0.5 | GO:0006570 | tyrosine metabolic process(GO:0006570) |
| 0.1 | 0.3 | GO:0072334 | UDP-galactose transport(GO:0015785) UDP-galactose transmembrane transport(GO:0072334) |
| 0.1 | 1.6 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 0.1 | 0.6 | GO:0040009 | regulation of growth rate(GO:0040009) |
| 0.1 | 0.2 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
| 0.1 | 2.8 | GO:1901687 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
| 0.1 | 0.8 | GO:1902739 | interferon-alpha secretion(GO:0072642) regulation of interferon-alpha secretion(GO:1902739) positive regulation of interferon-alpha secretion(GO:1902741) |
| 0.1 | 0.3 | GO:0090675 | intermicrovillar adhesion(GO:0090675) |
| 0.1 | 0.1 | GO:1902304 | positive regulation of potassium ion export(GO:1902304) |
| 0.1 | 0.3 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.1 | 0.1 | GO:0046338 | phosphatidylethanolamine catabolic process(GO:0046338) |
| 0.1 | 0.6 | GO:0052565 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
| 0.1 | 0.2 | GO:0021554 | optic nerve development(GO:0021554) |
| 0.1 | 1.2 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
| 0.1 | 1.3 | GO:0021702 | cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
| 0.1 | 0.3 | GO:0016139 | glycoside catabolic process(GO:0016139) |
| 0.1 | 0.5 | GO:0006127 | glycerophosphate shuttle(GO:0006127) |
| 0.1 | 10.3 | GO:0031295 | T cell costimulation(GO:0031295) |
| 0.1 | 0.2 | GO:0035372 | protein localization to microtubule(GO:0035372) |
| 0.1 | 0.6 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
| 0.1 | 1.5 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
| 0.1 | 0.2 | GO:0002215 | defense response to nematode(GO:0002215) |
| 0.1 | 0.2 | GO:0046502 | uroporphyrinogen III biosynthetic process(GO:0006780) uroporphyrinogen III metabolic process(GO:0046502) |
| 0.1 | 0.4 | GO:1904031 | positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
| 0.1 | 0.3 | GO:0061724 | sphinganine metabolic process(GO:0006667) lipophagy(GO:0061724) regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
| 0.1 | 0.4 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
| 0.1 | 0.3 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
| 0.1 | 0.3 | GO:1901207 | regulation of heart looping(GO:1901207) |
| 0.1 | 0.9 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
| 0.1 | 1.5 | GO:0002093 | auditory receptor cell morphogenesis(GO:0002093) |
| 0.1 | 0.4 | GO:0022900 | electron transport chain(GO:0022900) |
| 0.1 | 0.3 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
| 0.1 | 0.3 | GO:0030222 | eosinophil differentiation(GO:0030222) |
| 0.1 | 0.3 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
| 0.1 | 0.3 | GO:0060168 | positive regulation of adenosine receptor signaling pathway(GO:0060168) |
| 0.1 | 0.3 | GO:0097676 | histone H3-K36 dimethylation(GO:0097676) |
| 0.1 | 1.5 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
| 0.1 | 0.5 | GO:0032377 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.1 | 0.4 | GO:0010732 | protein glutathionylation(GO:0010731) regulation of protein glutathionylation(GO:0010732) negative regulation of protein glutathionylation(GO:0010734) |
| 0.1 | 0.2 | GO:0044650 | virion attachment to host cell(GO:0019062) adhesion of symbiont to host cell(GO:0044650) |
| 0.1 | 0.3 | GO:0048205 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
| 0.1 | 0.1 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
| 0.1 | 0.9 | GO:1903012 | positive regulation of bone development(GO:1903012) |
| 0.1 | 0.8 | GO:0043615 | astrocyte cell migration(GO:0043615) |
| 0.1 | 1.1 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
| 0.1 | 0.9 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.1 | 0.2 | GO:0000415 | negative regulation of histone H3-K36 methylation(GO:0000415) |
| 0.1 | 0.4 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
| 0.1 | 0.1 | GO:0035494 | SNARE complex disassembly(GO:0035494) |
| 0.1 | 1.5 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
| 0.1 | 0.9 | GO:0015824 | proline transport(GO:0015824) |
| 0.1 | 0.2 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
| 0.1 | 0.2 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
| 0.1 | 0.2 | GO:0032242 | regulation of nucleoside transport(GO:0032242) |
| 0.1 | 0.2 | GO:0001812 | positive regulation of type I hypersensitivity(GO:0001812) |
| 0.1 | 0.7 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
| 0.1 | 0.1 | GO:1902954 | regulation of early endosome to recycling endosome transport(GO:1902954) |
| 0.1 | 0.2 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
| 0.1 | 0.2 | GO:0032765 | regulation of mast cell cytokine production(GO:0032763) positive regulation of mast cell cytokine production(GO:0032765) |
| 0.1 | 0.6 | GO:0071386 | cellular response to corticosterone stimulus(GO:0071386) |
| 0.1 | 0.5 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
| 0.1 | 0.2 | GO:0032053 | ciliary basal body organization(GO:0032053) |
| 0.1 | 0.6 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
| 0.1 | 0.2 | GO:0042214 | terpene metabolic process(GO:0042214) |
| 0.1 | 0.1 | GO:0072425 | signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) |
| 0.1 | 0.6 | GO:0003214 | cardiac left ventricle morphogenesis(GO:0003214) |
| 0.1 | 0.2 | GO:0072683 | T cell extravasation(GO:0072683) |
| 0.1 | 0.2 | GO:0009597 | detection of virus(GO:0009597) |
| 0.1 | 0.8 | GO:0070269 | pyroptosis(GO:0070269) |
| 0.1 | 0.3 | GO:0046520 | sphingoid biosynthetic process(GO:0046520) |
| 0.1 | 0.7 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
| 0.1 | 0.2 | GO:0060370 | susceptibility to T cell mediated cytotoxicity(GO:0060370) |
| 0.1 | 0.4 | GO:0048505 | regulation of development, heterochronic(GO:0040034) regulation of timing of cell differentiation(GO:0048505) |
| 0.1 | 0.3 | GO:0070901 | mitochondrial tRNA methylation(GO:0070901) |
| 0.1 | 1.3 | GO:0006020 | inositol metabolic process(GO:0006020) |
| 0.1 | 0.1 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
| 0.1 | 0.1 | GO:0014034 | neural crest cell fate commitment(GO:0014034) |
| 0.1 | 0.7 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 0.1 | 0.1 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
| 0.1 | 2.2 | GO:0045332 | phospholipid translocation(GO:0045332) |
| 0.1 | 1.0 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
| 0.1 | 0.1 | GO:0090045 | positive regulation of histone deacetylation(GO:0031065) positive regulation of deacetylase activity(GO:0090045) positive regulation of histone deacetylase activity(GO:1901727) |
| 0.1 | 0.6 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
| 0.1 | 1.7 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
| 0.1 | 2.4 | GO:0034340 | response to type I interferon(GO:0034340) |
| 0.1 | 0.1 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
| 0.1 | 0.2 | GO:0098582 | innate vocalization behavior(GO:0098582) |
| 0.1 | 0.4 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
| 0.1 | 0.4 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
| 0.1 | 0.1 | GO:0050720 | interleukin-1 beta biosynthetic process(GO:0050720) |
| 0.1 | 0.5 | GO:2000095 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
| 0.1 | 0.6 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
| 0.1 | 0.5 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) |
| 0.1 | 0.3 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
| 0.1 | 0.3 | GO:2001295 | malonyl-CoA biosynthetic process(GO:2001295) |
| 0.1 | 0.1 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
| 0.1 | 0.2 | GO:1903281 | positive regulation of calcium:sodium antiporter activity(GO:1903281) |
| 0.1 | 1.3 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
| 0.1 | 0.3 | GO:1903788 | mycotoxin catabolic process(GO:0043387) aflatoxin catabolic process(GO:0046223) organic heteropentacyclic compound catabolic process(GO:1901377) regulation of glutathione biosynthetic process(GO:1903786) positive regulation of glutathione biosynthetic process(GO:1903788) |
| 0.1 | 0.4 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
| 0.1 | 0.5 | GO:0003183 | mitral valve morphogenesis(GO:0003183) |
| 0.1 | 0.5 | GO:0015705 | iodide transport(GO:0015705) |
| 0.1 | 0.4 | GO:0070383 | DNA cytosine deamination(GO:0070383) |
| 0.1 | 0.2 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
| 0.1 | 0.5 | GO:0098989 | NMDA selective glutamate receptor signaling pathway(GO:0098989) |
| 0.1 | 0.3 | GO:0019859 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) uracil metabolic process(GO:0019860) thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
| 0.1 | 0.5 | GO:0061049 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.1 | 0.1 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
| 0.1 | 0.2 | GO:1903984 | regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
| 0.1 | 0.5 | GO:0030242 | pexophagy(GO:0030242) |
| 0.1 | 0.2 | GO:0035281 | pre-miRNA export from nucleus(GO:0035281) |
| 0.1 | 0.4 | GO:0042733 | embryonic digit morphogenesis(GO:0042733) |
| 0.1 | 0.5 | GO:0031437 | regulation of mRNA cleavage(GO:0031437) regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904720) |
| 0.1 | 0.5 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
| 0.1 | 0.8 | GO:0015747 | urate transport(GO:0015747) |
| 0.1 | 0.1 | GO:0070541 | response to platinum ion(GO:0070541) |
| 0.1 | 1.0 | GO:1900364 | negative regulation of mRNA polyadenylation(GO:1900364) |
| 0.1 | 0.2 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.1 | 0.3 | GO:1903751 | regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
| 0.1 | 0.2 | GO:0018057 | peptidyl-lysine oxidation(GO:0018057) |
| 0.1 | 0.1 | GO:1903719 | regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
| 0.1 | 0.5 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
| 0.1 | 1.0 | GO:0006527 | arginine catabolic process(GO:0006527) |
| 0.1 | 0.4 | GO:0036507 | protein demannosylation(GO:0036507) protein alpha-1,2-demannosylation(GO:0036508) endoplasmic reticulum mannose trimming(GO:1904380) |
| 0.1 | 0.2 | GO:1900365 | positive regulation of mRNA polyadenylation(GO:1900365) |
| 0.1 | 0.2 | GO:0036079 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
| 0.1 | 0.2 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
| 0.1 | 0.2 | GO:1902616 | acyl carnitine transport(GO:0006844) acyl carnitine transmembrane transport(GO:1902616) |
| 0.1 | 0.5 | GO:1902219 | negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
| 0.1 | 0.3 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
| 0.1 | 0.2 | GO:0002101 | tRNA wobble cytosine modification(GO:0002101) |
| 0.1 | 0.4 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
| 0.1 | 0.4 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
| 0.1 | 0.2 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
| 0.1 | 0.2 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
| 0.1 | 0.7 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
| 0.1 | 0.1 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
| 0.1 | 0.2 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
| 0.1 | 0.4 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.1 | 0.2 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.1 | 0.4 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
| 0.1 | 0.5 | GO:0002191 | cap-dependent translational initiation(GO:0002191) |
| 0.1 | 0.2 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.1 | 0.2 | GO:1904247 | positive regulation of polynucleotide adenylyltransferase activity(GO:1904247) |
| 0.1 | 0.2 | GO:0071469 | cellular response to alkaline pH(GO:0071469) |
| 0.1 | 0.5 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
| 0.1 | 1.0 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
| 0.1 | 0.3 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
| 0.1 | 0.5 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
| 0.1 | 0.4 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
| 0.1 | 0.3 | GO:1902622 | regulation of neutrophil migration(GO:1902622) |
| 0.1 | 0.2 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
| 0.1 | 0.2 | GO:0021898 | commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) regulation of amacrine cell differentiation(GO:1902869) |
| 0.1 | 0.2 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
| 0.1 | 0.2 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
| 0.1 | 0.6 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
| 0.1 | 0.6 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.1 | 0.3 | GO:0006489 | dolichyl diphosphate biosynthetic process(GO:0006489) dolichyl diphosphate metabolic process(GO:0046465) |
| 0.1 | 0.3 | GO:1904579 | response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) response to hypobaric hypoxia(GO:1990910) |
| 0.1 | 0.1 | GO:0071320 | cellular response to cAMP(GO:0071320) |
| 0.1 | 1.0 | GO:0034587 | piRNA metabolic process(GO:0034587) |
| 0.1 | 0.3 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
| 0.1 | 0.3 | GO:0070543 | response to linoleic acid(GO:0070543) |
| 0.1 | 0.5 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
| 0.1 | 0.8 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
| 0.1 | 0.1 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
| 0.1 | 1.6 | GO:0035338 | long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
| 0.1 | 0.4 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
| 0.1 | 10.3 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.1 | 2.6 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
| 0.1 | 0.3 | GO:0090240 | positive regulation of histone H4 acetylation(GO:0090240) |
| 0.1 | 0.2 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
| 0.1 | 0.1 | GO:0070091 | glucagon secretion(GO:0070091) |
| 0.1 | 0.7 | GO:0035067 | negative regulation of histone acetylation(GO:0035067) |
| 0.1 | 0.3 | GO:1904970 | brush border assembly(GO:1904970) |
| 0.1 | 0.2 | GO:0038203 | TORC2 signaling(GO:0038203) |
| 0.1 | 0.5 | GO:1904153 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 0.1 | 0.2 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
| 0.1 | 0.2 | GO:0044205 | 'de novo' UMP biosynthetic process(GO:0044205) |
| 0.1 | 0.1 | GO:1990637 | response to prolactin(GO:1990637) |
| 0.1 | 0.3 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
| 0.1 | 0.3 | GO:0071503 | response to heparin(GO:0071503) |
| 0.1 | 0.4 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
| 0.1 | 3.7 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.1 | 0.1 | GO:0052314 | phytoalexin metabolic process(GO:0052314) |
| 0.1 | 0.3 | GO:0050955 | thermoception(GO:0050955) |
| 0.1 | 0.3 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) |
| 0.1 | 0.3 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
| 0.1 | 0.2 | GO:1902530 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 0.1 | 0.1 | GO:0060823 | canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060823) |
| 0.1 | 1.9 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
| 0.1 | 0.3 | GO:0051697 | protein delipidation(GO:0051697) |
| 0.1 | 0.3 | GO:1901093 | regulation of protein tetramerization(GO:1901090) negative regulation of protein tetramerization(GO:1901091) regulation of protein homotetramerization(GO:1901093) negative regulation of protein homotetramerization(GO:1901094) |
| 0.1 | 0.2 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.1 | 0.6 | GO:0032119 | sequestering of zinc ion(GO:0032119) |
| 0.1 | 1.0 | GO:0010447 | response to acidic pH(GO:0010447) |
| 0.1 | 0.2 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
| 0.1 | 1.0 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
| 0.1 | 0.2 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
| 0.1 | 0.2 | GO:0015993 | molecular hydrogen transport(GO:0015993) |
| 0.1 | 0.1 | GO:0045917 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
| 0.1 | 0.2 | GO:1903824 | regulation of telomere maintenance via recombination(GO:0032207) negative regulation of telomere maintenance via recombination(GO:0032208) regulation of telomere maintenance via semi-conservative replication(GO:0032213) negative regulation of telomere maintenance via semi-conservative replication(GO:0032214) negative regulation of single strand break repair(GO:1903517) negative regulation of beta-galactosidase activity(GO:1903770) telomere single strand break repair(GO:1903823) negative regulation of telomere single strand break repair(GO:1903824) |
| 0.1 | 0.1 | GO:0015698 | inorganic anion transport(GO:0015698) |
| 0.1 | 0.2 | GO:1902031 | regulation of pentose-phosphate shunt(GO:0043456) regulation of NADP metabolic process(GO:1902031) |
| 0.1 | 0.2 | GO:0010587 | miRNA catabolic process(GO:0010587) |
| 0.1 | 0.2 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
| 0.0 | 0.2 | GO:0060897 | neural plate anterior/posterior regionalization(GO:0021999) neural plate regionalization(GO:0060897) |
| 0.0 | 0.9 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
| 0.0 | 0.2 | GO:0071733 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
| 0.0 | 0.3 | GO:0030450 | regulation of complement activation, classical pathway(GO:0030450) negative regulation of complement activation, classical pathway(GO:0045959) |
| 0.0 | 0.2 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
| 0.0 | 0.2 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
| 0.0 | 0.1 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
| 0.0 | 0.2 |